XIth Eurasian Hematology-Oncology Congress - EHOC 2020

 

XIth Eurasian Hematology-Oncology Congress - EHOC 2020
F

Anti-T Cell pAbs for GVHD Prevention: Does the Addition of ATLG Grafalon to Standard Cyclosporin+Methotrexate Reduce cGVHD Incidence and Improve cGRFS?

By XIth Eurasian Hematology-Oncology Congress - EHOC 2020 FEATURING Francesca Bonifazi
By XIth Eurasian Hematology-Oncology Congress - EHOC 2020 FEATURING Francesca Bonifazi
6 views
January 18, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…

Feat. A. Zhou

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
Benign Hematology
27:49
XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Haploidentical Transplant in Developing Countries: Challenges, Moder…

Feat. G. Karasu
23:18
XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Curative Options for Hemoglobinopathies: Is MSD the SoC in Thalassem…

Feat. S. Corbacioglu
12:45
XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Anti-T Cell pAbs for GVHD Prevention: Does the Addition of ATLG Graf…

Feat. F. Bonifazi
21:57
XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Bone Marrow Failure: Aplastic Anemias, Telomere Diseases, GATA2 Defi…

Feat. R. Calado
14:49
XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Infections in Immunocompromised Patients: Immunodeficiencies in Bone…

Feat. M. Nucci
19:30
XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Paroxysmal Nocturnal Hemoglobinuria: Epidemiology, Classification, R…

Feat. H. Hamed
03:38
XIth Eurasian Hematology-Oncology Congress - EHOC 2020

2 y/o With Ecchymoses, Hepatosplenomegaly and Cervical Lymphadenopat…

Feat. C. Coskun
14:22
XIth Eurasian Hematology-Oncology Congress - EHOC 2020

ASFA Guidelines on the Use of Therapeutic Apheresis: What Does the G…

Feat. N. Dunbar
19:17
XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Managing Late Complications in Beta Thalassemia: Thrombotic Disease,…

Feat. V. Huseynov
23:20
XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Sickle Cell Disease: Pathogenesis, When to Recommend MSD-SCT, Antico…

Feat. S. Alkindi
23:55
XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Hemophilia Treatment in Developing Countries: What Are the Principle…

Feat. B. Antmen
17:36
XIth Eurasian Hematology-Oncology Congress - EHOC 2020

ITP Updates: Which Immune Suppressants Should We Use? What Is the Ef…

Feat. D. Provan